Randomized Phase III Trial of 5-FU Based Maintenance Therapy With or Without Panitumumab in Patients With RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX + Panitumumab
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 25 Oct 2017
At a glance
- Drugs Panitumumab (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 17 Oct 2017 Planned End Date changed from 9 Oct 2022 to 18 Dec 2022.
- 17 Oct 2017 Planned primary completion date changed from 9 Oct 2021 to 18 Dec 2021.
- 17 Oct 2017 Planned initiation date changed from 9 Oct 2017 to 18 Dec 2017.